Highbridge Capital Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,700
Closed -$207K 905
2018
Q2
$207K Sell
4,700
-3,600
-43% -$169K ﹤0.01% 816
2018
Q1
$418K Buy
8,300
+4,100
+98% +$241K 0.01% 748
2017
Q4
$277K Buy
+4,200
New +$267K ﹤0.01% 1275
2017
Q3
Sell
-4,700
Closed -$304K 1818
2017
Q2
$304K Buy
+4,700
New +$297K ﹤0.01% 960
2015
Q4
Sell
-5,800
Closed -$293K 1854
2015
Q3
$293K Buy
+5,800
New +$309K ﹤0.01% 1241

Other funds holding XRAY

Highbridge Capital Management's XRAY Position: Q3 2018 in Review

Highbridge Capital Management sold out of Dentsply Sirona (XRAY) in Q3 2018, closing a stake of 186,849 shares — an estimated $8.18M sold.

Highbridge Capital Management first reported a position in XRAY in Q1 2014 and held it in 8 quarters. The position peaked at $12M in Q1 2018. 522 funds tracked by Wall St. Rank hold XRAY as of Q3 2018.

  • Highbridge Capital Management reported no remaining Dentsply Sirona position as of Q3 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 186,849 Dentsply Sirona shares in Q3 2018, an estimated $8.18M.
  • Highbridge Capital Management first reported a position in Dentsply Sirona in Q1 2014 and held it in 8 quarters.
  • Highbridge Capital Management's Dentsply Sirona position peaked at $12M in Q1 2018.
  • 522 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.